Prime Body Wellness - Manhattan

Prime Body Wellness operates in Manhattan, New York, providing peptide-based weight management protocols and aesthetic wellness services through in-person consultations. The clinic focuses on medically supervised programs that combine pharmaceutical-grade peptides with comprehensive metabolic assessment, serving patients throughout New York City who seek evidence-based approaches to body composition and longevity medicine. Unlike telehealth-only providers, Prime Body Wellness requires initial in-person evaluation to establish baseline health markers and ensure appropriate candidate selection for peptide interventions.

The clinic's weight management protocols center on GLP-1 receptor agonists including semaglutide and tirzepatide, administered under physician oversight with dosing titration based on individual response and tolerance. Semaglutide programs typically begin at 0.25mg weekly with gradual escalation, while tirzepatide protocols start at 2.5mg weekly, both adjusted according to glycemic control, appetite suppression, and gastrointestinal tolerance. Prime Body Wellness incorporates NAD+ (nicotinamide adenine dinucleotide) therapy as an adjunct treatment, offering both intravenous and subcutaneous administration options to support cellular energy metabolism during caloric restriction phases. The NAD+ protocols are designed to mitigate fatigue and support mitochondrial function that can decline during weight loss, with dosing protocols ranging from 250mg to 1000mg depending on patient goals and response. Each peptide program includes body composition analysis, metabolic panel monitoring, and adjustment protocols to optimize results while minimizing adverse effects common to incretin-based therapies.

The medical team at Prime Body Wellness in Manhattan conducts comprehensive intake assessments that include thyroid function testing, insulin sensitivity markers, and lipid panels before initiating peptide therapy. Providers evaluate contraindications specific to GLP-1 agonists, including personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2, ensuring patient safety aligns with FDA prescribing guidelines. The clinic's approach integrates peptide therapy with nutritional guidance addressing protein intake requirements during weight loss, typically recommending 1.2-1.6 grams per kilogram of ideal body weight to preserve lean muscle mass. Follow-up protocols occur at four-week intervals during the initial titration phase, with laboratory monitoring of hemoglobin A1c, liver enzymes, and lipase levels to detect potential complications early.

Patients attending Prime Body Wellness in New York undergo initial consultations lasting approximately 60 minutes, during which providers review medical history, current medications, and weight loss history to determine appropriate peptide selection. The clinic maintains a Manhattan location that accommodates working professionals with extended hours, though all treatment protocols require in-person injection training and initial administration observation. Semaglutide and tirzepatide are dispensed in pre-filled pens with detailed injection technique instruction, and patients receive direct provider contact information for questions regarding side effects such as nausea, constipation, or injection site reactions. The aesthetic services component addresses skin laxity and volume loss that can accompany significant weight reduction, offering complementary treatments that patients often pursue once weight stabilization occurs.

Prime Body Wellness differentiates itself in the Manhattan wellness market through its requirement for in-person medical evaluation rather than algorithm-based telehealth prescribing, ensuring peptide therapy candidates receive appropriate screening and monitoring. The clinic's NAD+ integration addresses a common complaint among GLP-1 users—persistent fatigue during active weight loss—by supporting cellular energy production at the mitochondrial level. With a 5.0-star rating based on patient feedback, the practice has developed protocols that balance efficacy with tolerability, adjusting peptide dosing based on individual response rather than following rigid titration schedules. New York patients seeking medically supervised peptide therapy with hands-on provider access rather than remote prescription services find the clinic's model provides accountability and safety monitoring that purely telehealth platforms cannot replicate.